Qvest Group Acquires OnPrem Solution Partners LLC
The Qvest Group, a world-leading systems architect and ICT integrator, today announced the acquisition of the majority of OnPrem Solution Partners LLC, a highly reputed consultancy across the media and entertainment supply chain in the USA. OnPrem’s expertise in business and technology consulting, especially its focus on the digital media supply chain, will complement and extend the Qvest Group’s portfolio and lay the foundation to gain a foothold on the US-American market.
Headquartered in Los Angeles, with additional offices in New York and Austin, OnPrem is an end-to-end solution provider that strategizes, advises, designs and develops technology solutions, leveraging their expertise in content, customers and data for media and entertainment and consumer products industries. The acquisition brings a highly experienced team of more than 250 consultants to deliver solutions in areas such as Digital Media Supply Chain, IP and Rights Management, Data and Analytics, Customer Experience Design, Salesforce and Program Management/PMO to the Qvest Group. OnPrem has built dynamic partnerships with leading technology providers and platforms such as AWS, Salesforce and Microsoft.
“OnPrem strengthens the position of the Qvest Group as a leading partner in digital media, data and cloud management and considerably enhances our capacity to provide clients with added value, scale, and world-class expertise,” said Peter Nöthen, CEO of the Qvest Group. “For Qvest, this is also the steppingstone to the largest market for broadcast & media in the world which significantly raises our international business in technology consultancy and systems integration. Moreover, joining forces with OnPrem enables us to better and directly support worldwide operating clients and it also generates the ground for the growth of our cloud management platform qibb in the US-American market.”
Frank Leal, Partner at OnPrem, agrees: “The leadership at OnPrem is excited and inspired by our new Qvest partnership. With Qvest’s focus on the media industry and quality and their international presence, there was no better fit for us. This transaction creates a worldwide entity that is a partner to CTOs, CIOs and Broadcast Engineers everywhere. Most importantly, we were able to join a leadership team with a similar philosophy on culture and talent, providing additional opportunities for our team members and creating an organization that is a home to the best consultants and engineers in the world.”
The Qvest Group, headquartered in Germany, has offices across Europe, the Middle East, APAC, and Australia. The company has been accelerating the digital transformation of its clients, offering capabilities in technology design consultancy and systems integration, software development, cloud engineering, and technical infrastructure operations.
For OnPrem, Qvest’s service offerings and global scale will help to meet its clients’ growing needs for architecture design, seamless technology integration and realizing large-scaled media infrastructure projects along the entire digital media value chain.
As part of the acquisition, the Qvest Group acquired 55 % of the shares in OnPrem. The contract was signed on December 2, 2020. The partners at OnPrem, Frank Leal, Candice Lu, Christophe Ponsart, Jon Christian, and Vanessa Fiola, along with leadership will continue to build on its long-standing, valued relationships with employees and clients.
About Qvest Group
Qvest is a world-leading systems architect, consultant and ICT integrator in the innovation-driven media industry. The company’s range of services is aligned to the opportunities emerging from an increasingly digital media value chain such as multi-platform content delivery, AI, big data analysis, multi-cloud management and IP infrastructures. Qvest Media’s clients include renowned media networks, telecommunication providers, broadcasters, companies and organizations from the industrial and public sector. Next to the headquarters in Cologne, Qvest Media operates further locations in Europe, the USA, MENA & APAC.
OnPrem Solution Partners is an end-to-end solution provider that strategizes, advises, designs, develops and integrates world-class technology. Experts in Digital Media Supply Chain, IP and Rights Management, CRM, AI, Data & Analytics, PMO/Project management and custom development, OnPrem connects disparate parts of an organization to enable operational excellence. Based in Los Angeles with offices in New York and Austin Texas, OnPrem offers its expertise within the Media & Entertainment, Consumer Packaged Goods industries and more.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF ® + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy16.1.2021 22:15:00 CET | Press release
Servier announced today updated results from the exploratory phase II TASCO1 study evaluating LONSURF® (trifluridine/tipiracil) + bevacizumab and capecitabine + bevacizumab (C-B) in a first-line setting for patients with unresectable metastatic colorectal cancer (mCRC) who are non-eligible for intensive therapy.1 The data were announced today during an oral presentation at the 2021 ASCO Gastrointestinal Cancers Symposium (ASCO-GI). Patients with mCRC who are not eligible for chemotherapy face a large unmet need, with fewer treatment options available to them and lower survival rates. Colorectal cancer (CRC) makes up 9.7% of total global cancer cases, with almost 1.4 million new cases of CRC each year.2 In Europe, CRC is the second most common cause of death due to cancer, and those with a metastatic disease have a 5-year survival rate of just 11%.3 “For patients with metastatic colorectal cancer, those non-eligible for standard combination therapy have few options left and we are conti
H.I.G. Realty Invests in Production Studios & Content Hub in Madrid15.1.2021 09:00:00 CET | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with $43 billion of equity capital under management, announced today that one of its affiliates has invested in Madrid Content City, an approximately 140,000 square meter hub with state of the art audio-visual facilities, including production studios, production & post-production technical facilities, and a university focused on media studies. H.I.G. continues to add to its sizeable portfolio of real estate assets across Europe, consisting of both equity as well as debt investments, with a particular focus on its target market of value-added small and midcap opportunities. Riccardo Dallolio, Managing Director and Head of H.I.G. Europe Realty Partners, commented: “Madrid Content City will benefit from strong secular tailwinds underpinned by the boom in content production. The state-of-the-art studios and related facilities, the exceptional multinational tenant line-up with long term leases, and its critical mas
Eurofins, the global leader in analytical testing, expands worldwide face mask testing & certification capabilities15.1.2021 07:30:00 CET | Press release
Since the start of the pandemic Eurofins (Paris:ERF) has tested thousands of models of surgical and hygienic masks and provided best-in-class speed and certification for PPEs globally, enabling these critical products to get market as fast as possible. Eurofins has developed global leading testing capabilities and certification services in the North America, Europe and Asia ensuring that PPE manufacturers are able to provide the indispensable support needed in the fight against the coronavirus. As of today, Eurofins is one of the few GLP certified and ISO/IEC 17025 accredited laboratory networks to fully cover all testing requirements for surgical/medical and hygienic masks by the FDA, EU regulations and many international and country-specific directives and guidelines such as CEN, CE Marking, ISO, ASTM or OECD. Our robust portfolio for masks includes globally accepted, safety and performance testing, virucidal, bacterial filtration, particle filtration, differential pressure, biocompa
TOXINS 2021: New analyses of pivotal Phase III trial data highlight long duration of response for Dysport ® (abobotulinumtoxinA) in five therapeutic indications15.1.2021 07:00:00 CET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced results from new analyses of pivotal Phase III clinical trial data to assess treatment intervals over repeat cycles of Dysport® (abobotulinumtoxinA [aboBoNT-A]) in five patient populations. AbobotulinumtoxinA: Evidence for Long Duration of Response from 5 Patient Populations is being shared during the TOXINS 2021 conference, which is taking place virtually between 16-17 January 2020 and is organized by the International Neurotoxin Association.1-28 Ipsen is sharing 26 abstracts during the congress, with data including updates from the recently published surveys into the experience of patients and caregivers, data from the Phase IV ULIS-III trial, and ten abstracts focused on basic science research into neurotoxins.1-27 Spasticity is one of the most common and disabling conditions associated with many neurological conditions in adults and is characterized by velocity-dependent muscle hypertonia. Spasticity can lead to disabilit
Velodyne Lidar Commends NHTSA Plan to Update NCAP14.1.2021 21:58:00 CET | Press release
Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today commended the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA) plan to update to its New Car Assessment Program (NCAP). The NHTSA proposal would add four advanced driver assistance system (ADAS) capabilities to the NCAP, keeping pace with evolving safety technologies and providing much-needed information to consumers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005992/en/ Images show vehicle with lidar-based PAEB stopping before adult target @ 50% overlap (above) and vehicle with camera and radar-based PAEB crashing into adult target (below). (Photo: Velodyne Lidar, Inc.) NCAP is the U.S. Government’s premier consumer information program for evaluating vehicle safety performance. The NHTSA proposal to add ADAS technologies to the NCAP includes pedestrian automatic emergency braking, lane keeping support, blind spot warning and
Snow Software Recognized as a 2020 Gartner Peer Insights Customers’ Choice for Software Asset Management14.1.2021 20:39:00 CET | Press release
Snow Software, the global leader in technology intelligence, today announced that the company was named a December 2020 Gartner Peer Insights Customers’ Choice for Software Asset Management (SAM) Tools. Gartner defines software asset management tools as technology that “automates many of the tasks required to maintain compliance with software licenses, thereby controlling software spending.” This is the fourth Gartner Peer Insights Customers’ Choice announcement for SAM, and Snow has earned the distinction all four times. Based solely on feedback from verified customers, Gartner Peer Insights Customers’ Choice reflects reviews and ratings published within the last 12 months. Snow received 100 reviews – the most of any vendor in the market – with an overall rating of 4.6 out of 5 as of January 12, 2021. Earlier this year, Snow was recognized as a Leader in Gartner’s 2020 Magic Quadrant for Software Asset Management Tools1 and received the highest scores in three out of four use cases in
Veristat Supported Marketing Applications for 10% of All FDA Novel Drug Approvals in 202014.1.2021 19:15:00 CET | Press release
Veristat, a scientific-minded global clinical research organization (CRO), announced today that they supported the marketing applications for 10% of the 2020 US Food and Drug Administration (FDA) novel drug approvals. The FDA approved 53 novel drugs, defined by the FDA as New Molecular Entities (NMEs)i, and Veristat regulatory, statistical, and medical writing experts were integral in preparing five of these NME New Drug Applications. Veristat also prepared NDA/BLAs for three non-NME FDA approvals and one Marketing Authorization Application (MAA) that received approval in Europe. "Despite the global challenges in 2020, Veristat continued to advance its mission of helping clients achieve regulatory approval of novel medical therapies," stated Patrick Flanagan, Chief Executive Officer at Veristat. "Now, more than ever, Veristat is focused on providing expert guidance to facilitate the rapid approval for therapies that improve the lives of patients and their families around the world." Ve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom